Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68481873 | 6848187 | 3 | F | 20080602 | 20160824 | 20081212 | 20160906 | EXP | US-PFIZER INC-2008048134 | PFIZER | 82.00 | YR | F | Y | 68.04000 | KG | 20160906 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68481873 | 6848187 | 1 | PS | CELECOXIB. | CELECOXIB | 1 | Oral | UNK | Y | 20998 | CAPSULE, HARD | ||||||||
| 68481873 | 6848187 | 2 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | QD | |||||||
| 68481873 | 6848187 | 3 | C | IRBESARTAN. | IRBESARTAN | 1 | Oral | QD | 0 | 150 | MG | ||||||||
| 68481873 | 6848187 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | QD | 0 | 5 | MG | ||||||||
| 68481873 | 6848187 | 5 | C | PAROXETINE. | PAROXETINE | 1 | Oral | QD | 0 | 20 | MG | ||||||||
| 68481873 | 6848187 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | QD | 0 | .088 | MG | ||||||||
| 68481873 | 6848187 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | QD | 0 | 20 | MG | ||||||||
| 68481873 | 6848187 | 8 | C | ESTROGENS CONJUGATED | ESTROGENS, CONJUGATED | 1 | Oral | 0.625 MG, 1X/DAY | 0 | .625 | MG | QD | |||||||
| 68481873 | 6848187 | 9 | C | KEFLEX | CEPHALEXIN | 1 | Oral | QD | 0 | 500 | MG | ||||||||
| 68481873 | 6848187 | 10 | C | LORTAB | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 7.5/500 MG,PRN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 68481873 | 6848187 | 1 | Osteoarthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 68481873 | 6848187 | OT |
| 68481873 | 6848187 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 68481873 | 6848187 | Drug hypersensitivity | |
| 68481873 | 6848187 | Follicle centre lymphoma, follicular grade I, II, III |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 68481873 | 6848187 | 1 | 20071128 | 20080602 | 0 | |
| 68481873 | 6848187 | 2 | 20071128 | 200806 | 0 | |
| 68481873 | 6848187 | 3 | 20051117 | 0 | ||
| 68481873 | 6848187 | 4 | 20051117 | 0 | ||
| 68481873 | 6848187 | 5 | 20051117 | 0 | ||
| 68481873 | 6848187 | 6 | 20051117 | 0 | ||
| 68481873 | 6848187 | 7 | 20051117 | 0 | ||
| 68481873 | 6848187 | 8 | 20061101 | 0 | ||
| 68481873 | 6848187 | 9 | 20080602 | 20080604 | 0 | |
| 68481873 | 6848187 | 10 | 20080602 | 0 |